← Eichor
Study identifier: NCT05803564 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Thoracoabdominal Aortic Stent System for Endovascular Treatment of Thoracoabdominal Aortic Dissecting Aneurysm.

Condition: Thoracoabdominal; Aortic, Aneurysm, Dissecting  ·  Sponsor: Lifetech Scientific (Shenzhen) Co., Ltd.

PhaseNA
Planned participants46
Who can joinAll sexes, 18 Years to 80 Years
Healthy volunteersNo

About this study

A First in man study to evaluate the safety and efficacy of thoracoabdominal aortic stent system for endovascular treatment of thoracoabdominal aortic dissecting aneurysm.

This description comes directly from the study's public registry record.

Talk to the study team

Wei Xu  ·  15695219339  ·  xuwei@lifetechmed.com

Always discuss trial participation with your own doctor first.

Locations (1)

Chinese PLA General HospitaBeijing, Beijing Municipality, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05803564